Fabio Ciceri Selected Research

Fabio Ciceri Research Topics

Disease

85	Leukemia 10/2022 - 11/2002
64	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 01/2006
55	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2022 - 01/2002
52	COVID-19 06/2022 - 01/2020
50	Neoplasms (Cancer) 01/2022 - 01/2002
24	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2002
23	Infections 02/2022 - 11/2004
22	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 04/2009
13	Pneumonia (Pneumonitis) 02/2022 - 01/2020
12	Lymphoma (Lymphomas) 12/2021 - 09/2004
12	Multiple Myeloma 12/2021 - 12/2002
9	Philadelphia Chromosome 01/2021 - 08/2010
8	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 07/2009
7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2020 - 07/2008
6	Inflammation (Inflammations) 10/2021 - 07/2014
6	Hodgkin Disease (Hodgkin's Disease) 11/2020 - 03/2008
5	Fever (Fevers) 01/2022 - 07/2014
5	Severe combined immunodeficiency due to adenosine deaminase deficiency 01/2021 - 01/2009
5	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2021 - 01/2009
5	Residual Neoplasm 12/2020 - 04/2009
5	beta-Thalassemia (Cooley's Anemia) 06/2011 - 09/2007
4	Pathologic Complete Response 10/2022 - 01/2002
4	Respiratory Insufficiency (Respiratory Failure) 02/2022 - 01/2021
4	Cytokine Release Syndrome 11/2021 - 01/2018
4	Hematologic Diseases (Blood Diseases) 01/2021 - 03/2010
4	Hypertension (High Blood Pressure) 09/2020 - 01/2009
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 09/2004
4	Disease Progression 01/2020 - 06/2005
4	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 12/2019 - 08/2013
4	Thalassemia 01/2019 - 05/2010
4	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 05/2011
3	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022 - 11/2009
3	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2022 - 01/2021
3	Anemia 10/2021 - 04/2011
3	Primary Myelofibrosis (Myelosclerosis) 01/2021 - 09/2016
3	Multiple Sclerosis 01/2021 - 06/2005
3	Cardiotoxicity 05/2020 - 01/2018
3	Bronchiolitis Obliterans Syndrome 02/2020 - 01/2015

Drug/Important Bio-Agent (IBA)

41	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 01/2002
20	AntigensIBA 01/2022 - 11/2004
15	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2006
11	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 11/2008
10	CytokinesIBA 01/2022 - 11/2004
9	C-Reactive ProteinIBA 01/2022 - 11/2005
9	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2021 - 01/2017
9	Rituximab (Mabthera)FDA Link 11/2020 - 07/2008
8	treosulfanIBA 01/2022 - 08/2015
8	Tyrosine Kinase InhibitorsIBA 01/2022 - 10/2016
8	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 12/2009
8	Interleukin-6 (Interleukin 6)IBA 04/2021 - 01/2018
8	Pharmaceutical PreparationsIBA 11/2020 - 05/2015
8	Thymidine KinaseIBA 06/2013 - 11/2002
7	Busulfan (Busulfex)FDA Link 01/2022 - 01/2009
6	Interleukin-1 (Interleukin 1)IBA 04/2021 - 01/2018
6	Biological ProductsIBA 11/2020 - 04/2012
5	fludarabineIBA 01/2022 - 01/2002
5	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2022 - 12/2009
5	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2018
5	VaccinesIBA 01/2022 - 02/2009
5	SteroidsIBA 10/2021 - 11/2004
5	Monoclonal AntibodiesIBA 01/2021 - 01/2018
4	AutoantibodiesIBA 01/2022 - 10/2020
4	TroponinIBA 01/2022 - 01/2018
4	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 10/2007
4	Sirolimus (Rapamycin)FDA Link 01/2022 - 01/2011
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 05/2012
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 09/2019
4	AntibodiesIBA 11/2021 - 05/2010
4	Oxygen (Dioxygen)IBA 10/2021 - 04/2020
4	Adenosine DeaminaseIBA 01/2021 - 01/2009
4	Complement System Proteins (Complement)IBA 11/2020 - 01/2020
4	Hemoglobins (Hemoglobin)IBA 01/2019 - 11/2005
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 10/2021
3	Immunoglobulin G (IgG)IBA 01/2022 - 10/2020
3	defibrotideIBA 01/2022 - 01/2018
3	HLA-A Antigens (HLA-A)IBA 01/2022 - 04/2017
3	tocilizumab (atlizumab)FDA Link 11/2021 - 01/2018
3	IronIBA 10/2021 - 06/2012
3	Proteins (Proteins, Gene)FDA Link 10/2021 - 10/2007
3	fibrin fragment D (D-dimer)IBA 10/2021 - 04/2020
3	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2021 - 01/2018
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2020 - 03/2016
3	Calcineurin InhibitorsIBA 12/2020 - 03/2016
3	AnthracyclinesIBA 05/2020 - 01/2018
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 08/2015
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 11/2004

Therapy/Procedure

78	Hematopoietic Stem Cell Transplantation 10/2022 - 01/2006
74	Transplantation 10/2022 - 01/2002
60	Stem Cell Transplantation 01/2022 - 11/2002
42	Therapeutics 02/2022 - 06/2005
37	Cell Transplantation 01/2022 - 11/2002
25	Drug Therapy (Chemotherapy) 11/2021 - 03/2008
19	Haploidentical Transplantation 01/2022 - 07/2009
15	Immunotherapy 01/2022 - 11/2004
12	Homologous Transplantation 01/2020 - 01/2002
5	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2021 - 09/2014
5	Autologous Transplantation 08/2020 - 05/2010
4	Radiotherapy 04/2014 - 06/2009
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 10/2022 - 01/2017
3	Noninvasive Ventilation 01/2022 - 06/2020